Inhibrx Biosciences Inc

NAS:INBX (USA)  
$ 15.15 +0.65 (+4.49%) 11:08 PM EST
At Loss
Market Cap:
$ 219.31M
Enterprise V:
$ 221.99M
Volume:
258.02K
Avg Vol (2M):
364.30K
Trade In:
Volume:
258.02K
At Loss
Avg Vol (2M):
364.30K

Business Description

Compare
Compare
Traded in other countries / regions
INBX.USA
IPO Date
2024-05-28
Description
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what they believe to be the most appropriate agonist function.
Name Current Vs Industry Vs History
Equity-to-Asset -0.38
Debt-to-Equity -0.25
Debt-to-EBITDA -0.06
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 51.19
9-Day RSI 54.36
14-Day RSI 56.46

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.37
Quick Ratio 0.37

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -2535.68
ROA % -181.75
ROIC % -250.07
ROC (Joel Greenblatt) % -516.17

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 131.74
EV-to-EBIT -4.51
EV-to-EBITDA -4.54
EV-to-Revenue 135.86
EV-to-FCF -5.36
Earnings Yield (Greenblatt) % -22.17
FCF Yield % -18.89

Financials (Next Earnings Date:2024-08-30 Est.)

INBX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:INBX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Inhibrx Biosciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.634
EPS (TTM) ($) -3.46
Beta 0
Volatility % 0
14-Day RSI 56.46
14-Day ATR ($) 1.122252
20-Day SMA ($) 0
12-1 Month Momentum % 0
52-Week Range ($) 12.95 - 18.95
Shares Outstanding (Mil) 14.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Inhibrx Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Inhibrx Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Inhibrx Biosciences Inc Frequently Asked Questions

What is Inhibrx Biosciences Inc(INBX)'s stock price today?
The current price of INBX is $15.15. The 52 week high of INBX is $18.95 and 52 week low is $12.95.
When is next earnings date of Inhibrx Biosciences Inc(INBX)?
The next earnings date of Inhibrx Biosciences Inc(INBX) is 2024-08-30 Est..
Does Inhibrx Biosciences Inc(INBX) pay dividends? If so, how much?
Inhibrx Biosciences Inc(INBX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1